129 / 490
127
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
MONDAY 2 MAY 2016
> Changes of the density CD8+ tumour infiltrating lymphocytes after
neoadjuvant radiochemotherapy
D. Buka (Czech Republic), J. Dvorak, V. Sitorova, I. Richter, I. Sirak
PV-0431
> Mechanisms and abscopal effects of combined mRNA-based radioim-
munotherapy in a syngenic mouse model.
L. Basler (Germany), A. Kowalczyk, M. Fotin-Mleczek, K.J. Kallen,
D. Zips, S.M. Huber
PV-0432
Symposium
MODERN ART BASED ON FUNCTIONAL / BIOLOGICAL IMAGING
10:45 - 11:45 | ROOM 2
This session covers functional imaging for adaptive radiotherapy, with a focus on head and neck cancer.
FDG, hypoxia tracers such as F-MISO and FAZA and tracers for proliferation imaging are interesting
PET tracers that may be used in adaptive radiotherapy and for patient selection in targeted therapy.
How can these imaging modalities be incorporated in an adaptive workflow and what is the rol/
responsibility of the RTT in this process? As example the ARTFORCE trial is described, with a discus-
sion on the use of dose accumulation for assessment of local dose. Future perspectives on imaging and
adaptive replanning will be addressed.
Chair: U. Van der Heide (The Netherlands)
Co-chair: F. Alongi (Italy)
10:45 > Functional imaging for ART; biological bases and potential impact on
clinical outcome
Speaker: B. Hoeben (The Netherlands)
SP-0433
11:05 > Adaptive radiation therapy by the example of head and neck cancer: is
there any role for a RTT?
Speaker: B. Speleers (Belgium)
SP-0434
11:25 > Dosimetric impact of dose painting and replanning: ARTFORCE project
Speaker: J. Sonke (The Netherlands)
SP-0435
Symposium
SECONDARY CANCER AFTER RADIOTHERAPY: FROMCANCER
REGISTRIES TO CLINICAL IMPLICATIONS
10:45 - 11:45 | ROOM 4
Chair: L.P. Muren (Denmark)
Co-chair: A.R. Filippi (Italy)
10:45 > Radiotherapy-related second cancer risks from epidemiological studies,
and their application to newer therapies
Speaker: A. Berrington de González (USA)
SP-0436